To save lives, clinical trials need diversity
I’ve spent my entire career fighting for vulnerable patients, especially people of color. So I was ecstatic to hear about a new initiative from dozens of biotech companies. These firms pledged to enroll more people of color in “clinical trials” — the years-long tests that show whether experimental drugs are safe and effective. Historically, people…